05:38 PM EDT, 05/07/2024 (MT Newswires) -- Globus Medical ( GMED ) reported Q1 non-GAAP earnings late Tuesday of $0.72 per diluted share, up from $0.53 a year earlier.

Analysts surveyed by Capital IQ expected $0.57.

Net sales in the quarter ended March 31 surged to $606.7 million from $276.7 million a year earlier.

Analysts surveyed by Capital IQ expected $589.6 million.

The company boosted 2024 guidance to non-GAAP EPS of $2.75 to $2.85 on revenue of $2.46 billion to $2.49 billion from EPS of $2.68 to $2.70 on revenue of $2.45 billion to $2.48 billion.

Analysts surveyed by Capital IQ expect EPS of $2.69 on revenue of $2.48 billion.

Shares of the company jumped 11% in after-hours trading.

Price: 56.80, Change: +5.44, Percent Change: +10.59